What is Biofourmis?
Founded in 2015 and headquartered in Boston, Massachusetts, with additional offices in Singapore and India, Biofourmis specializes in AI-driven digital health solutions. Its core platform is engineered to collect and analyze over 120 biomarkers in real-time, enabling proactive clinical interventions by identifying critical health shifts. Biofourmis collaborates with health systems, payers, and life science companies to facilitate remote patient monitoring, virtual care delivery, and decentralized clinical trials. The company's strategic merger with CopilotIQ has further enhanced its end-to-end AI-driven in-home care platform, covering the continuum from pre-surgical optimization to acute and post-acute care management. This comprehensive approach aims to improve patient outcomes, reduce hospital readmissions, and accelerate drug development.
How much funding has Biofourmis raised?
Biofourmis has raised a total of $561.1M across 7 funding rounds:
Private Equity
$1M
Series A
$5M
Series B
$35M
Debt
$150K
Series C
$100M
Series D
$320M
Series C
$100M
Private Equity (2016): $1M with participation from SpesNet and Eden Strategy
Series A (2017): $5M led by The Northstar Group, Aviva, and NSI Ventures
Series B (2019): $35M, investors not publicly disclosed
Debt (2020): $150K featuring PPP
Series C (2020): $100M backed by Softbank Capital, EDBI, Openspace Ventures, MassMutual Ventures, and Steamboat Ventures
Series D (2022): $320M with participation from Trevor Fetter, CVS Health, and General Atlantic
Series C (2025): $100M led by Sequoia Capital, Openspace Ventures, Edbi, Massachusetts Mutual Life Insurance, and SoftBank Corp
Key Investors in Biofourmis
Sequoia Capital
Sequoia Capital is a prominent venture capital firm known for its long-term investment approach and active partnership with entrepreneurs. It invests across venture, growth, and late-stage opportunities, with a significant presence in India and globally, backing numerous market leaders.
Edbi
EDBI is a global investor based in Singapore that focuses on high-growth technology sectors, aiming to empower businesses and create sustainable legacies through strategic investments in areas like biotechnology and fintech.
CVS Health
CVS Health is a major healthcare company focused on delivering high-quality, affordable health care through various channels, aiming to improve health and well-being by providing connected experiences and lowering care costs.
What's next for Biofourmis?
The substantial capital infusion, particularly the recent strategic investment, positions Biofourmis for accelerated growth and innovation in the rapidly evolving digital health landscape. With a focus on expanding its AI capabilities and market reach, the company is poised to further solidify its leadership in remote patient monitoring and virtual care delivery. Future strategic initiatives are likely to involve deepening partnerships with healthcare providers and payers, enhancing its platform's predictive analytics, and potentially exploring new therapeutic areas for its technology-enabled care models. This sustained financial backing indicates strong investor confidence in Biofourmis's mission to transform healthcare delivery through advanced technology.
See full Biofourmis company page
